Placebo-subtracted mean weight loss up to 8.4% at Day 36 19-day observed half-life supports once-monthly dosing as monotherapy and potential first-in-category monthly GLP-1 + Amylin combination ...

The 8.4% weight loss mark reported Monday was achieved by the 1.2 mg dose, the highest of four doses of the drug administered weekly for five weeks in a two-part Phase 1 study. Each part enrolled ...

MILAN, June 12, 2025--Schrödinger announces encouraging initial clinical data from its ongoing Phase 1 dose-escalation study of SGR-1505.

Enrollment in both portions of the Phase 1/2 study is complete. Intellia dosed the first patient in the global Phase 3, randomized, double-blind, placebo-controlled HAELO trial in January of 2025.

As part of the previously announced ongoing Phase 2 readiness activities, the Company recently completed an additional 14-day multiple ascending dose cohort (n=10) in the Phase 1 clinical trial of ...

Explore the evolution of Clone Trooper armor from Phase I to Phase II, highlighting key design changes and tactical upgrades. This video breaks down the differences in helmet structure, armor ...

LOS ANGELES -- Two people were killed, including a longtime Los Angeles police sergeant, on the 405 Freeway, prompting the closure of all southbound lanes early Monday morning. A crash was ...

After a group stage played in front of more than 1 million empty seats, the Club World Cup moves on to knockout rounds that could soon resemble a Champions League clone.

In January, Novo recorded 22% weight loss in people who received weekly amycretin injections for 36 weeks in a phase 1b/2a study. The company didn’t mention whether weight loss appeared to ...

The study tested a range of single and multiple doses in 80 nondiabetic people with obesity or who are overweight. Compared to placebo, people who received five weekly 1.2-mg doses lost 8.4% of ...

President Donald Trump said Tuesday that he plans to phase out the Federal Emergency Management Agency after this year’s hurricane season, offering the clearest timeline yet for his ...